IMMB

Healthcare Biotechnology

Immunotech Laboratories, Inc.

$0.00

-0.00 -0.00% today

Price History

Not enough data

Key Stats

Market Cap

110.132

Avg Volume

4,027

EPS

-$0.04

52W High

$0.00

52W Low

$0.00

Div. Yield

0.0%

Valuation

P/B Ratio

0.00

Margins

Gross Margin 0.0%

Operating Margin 0.0%

Net Margin 0.0%

EBITDA Margin 0.0%

Liquidity & Leverage

Current Ratio

0.01

Quick Ratio

0.01

About

Immunotech Laboratories, Inc. develops and commercializes proprietary proteins for use in treating human immunodeficiency virus (HIV), acquired immune deficiency syndrome (AIDS), hepatitis, and other immuno-related disorders. Its flagship compound is ITV-1 (immune therapeutic vaccine), a suspension of irreversible pepsin fraction that is used in the treatment of HIV/AIDS and Hepatitis C, as well as to modulate the immune system. The company is headquartered in Monrovia, California. As of June 14, 2017, Immunotech Laboratories, Inc. operates as a subsidiary of Enzolytics, Inc.